Maurizio Scaltriti

Sloan-Kettering Inst Can Research

$2,372,241

Attributed

$2,980,804

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2014–23

$2M$1.5M$1M$500K$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$2,980,804 · 6

By mechanism

R01$2,086,777 · 2

R21$413,523 · 1

P50$304,920 · 2

R03$175,584 · 1

Top collaborators

Alexander Drilon2 shared

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Andrea Ventura$13,315,692
Gabriela Chiosis$23,584,161
Jason S Lewis$26,024,327
Samuel Singer$8,089,401
William Robert Jarnagin$4,049,789

Others in their field

Top investigators on “Pathway Interactions”

David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
David R. Weir · University Of Michigan At Ann Arbor$129,316,139
Daniel Ernest Ford · Johns Hopkins University$108,075,637
David W Simpson · University Of Southern California$88,046,235
Charles D. Blanke · Oregon Health And Science University$86,571,896

Research focus

Pathway InteractionsTumorMalignant NeoplasmsBaseGenesMalignant Breast NeoplasmBreast Cancer PatientTherapy ResistantMutationMolecularPlayResistanceSamplingInhibitor/AntagonistMonitorGenomicsGenerationsLeadResponseExome SequencingDiagnosisLeadershipPhosphotransferasesTumorigenic